about
Neuropharmacology of vestibular system disordersDiscovery and Development of Calcium Channel Blockers.Pharmacodynamic differentiation of lorazepam sleepiness and dizziness using an ordered categorical measureComparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.Clinical practice guideline: benign paroxysmal positional vertigo.Postsynaptic mechanisms underlying the excitatory action of histamine on medial vestibular nucleus neurons in rats.Neuropharmacological Targets for Drug Action in Vestibular Sensory Pathways.Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update).Na(+) -Ca(2+) Exchanger, Leak K(+) Channel and Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Comediate the Histamine-Induced Excitation on Rat Inferior Vestibular Nucleus Neurons.Vestibular effects of lidocaine intratympanic injection in rats.Excitatory effect of norepinephrine on neurons in the inferior vestibular nucleus and the underlying receptor mechanism.Teaching Patient-Centered Counseling Skills for Assessment, Diagnosis, and Management of Benign Paroxysmal Positional Vertigo.Betahistine Treatment in a Cat Model of Vestibular Pathology: Pharmacokinetic and Pharmacodynamic Approaches.Baclofen affects the semicircular canals but not the otoliths in humansPharmaceutical Countermeasures Have Opposite Effects on the Utricles and Semicircular Canals in Man
P2860
Q24624927-A0F546D9-37C5-4243-8357-3CC50E0027CCQ33734936-B3BBE2CF-EDE9-47F8-8F3B-C61AB9B2893EQ34055606-4E604823-4844-4178-A371-E6373CF30EDEQ34268484-F929B919-E0D4-4DBA-BE87-235468B1767FQ34869411-813B88DB-50A3-4032-988C-3D544F088ED3Q37151158-EEB9F45E-114B-40FC-89B6-DEC34FACBEE9Q42367598-2BD0459F-0F70-4717-9FA7-392B26539463Q45053750-AADEF25B-792C-4FA5-AC00-4B14A7F19CFCQ47650690-9B4E0BF5-F357-41AF-9694-DFA7F4ABA353Q47915103-3311321B-B1BF-40BD-B0E7-9AA9B9AF78DBQ48788724-7A130945-4FA8-415A-9566-2B3E0F67B3EBQ50106691-F1991239-BF6B-4218-908A-329489581BD4Q55407927-82C4DA69-5888-4F53-8B1A-297DB92944F4Q57809768-03C391B1-73B7-48F2-BC8C-697F770CD2E4Q57809888-E78D6C64-CCA8-4777-9F50-2D76B4EA969F
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacological treatment of vertigo.
@en
type
label
Pharmacological treatment of vertigo.
@en
prefLabel
Pharmacological treatment of vertigo.
@en
P1433
P1476
Pharmacological treatment of vertigo.
@en
P2093
Mohammed Uddin
Timothy C Hain
P304
P356
10.2165/00023210-200317020-00002
P577
2003-01-01T00:00:00Z
P5875
P6179
1045708408